ERBB2 and neoplasm: In order to facilitate researchers’ analysis of the specific subgroups they focused on, we developed a comprehensive and flexible interface that permits users to customize subgroups with single or combined clinical features of interest, including subtypes, grades, stages, metastasis status, lymph node status, prognosis, age, tumor size, ER/PR/HER2 status, TP53 mutation status, menopause status, and therapy response.